We can assist you in making sure that you are receiving the optimal financial benefit from the 340B Program relative to the inherent compliance risks of participating in the program.
We are offering a Complimentary Financial Analysis of your 340B Retail Pharmacy Program. If you would like one of our 340B consultants to analyze your retail program for possible revenue opportunities, feel free to contact us.
340B Implementation Assistance
- Provider-Based location development
- Revenue analysis
- Medicare cost report compilation
- Contract pharmacy negotiation
- 340B software selection
- HRSA registration
- Program monitoring
On December 28, 2018, a federal judge in Washington reversed the enormous cuts to Medicare OP Drug payments implemented by CMS which were effective January 1, 2018. U.S. District Judge Rudolph Contreras ruled CMS and HHS secretary exceeded their authority by cutting 340B reimbursement by approximately 28.5%. The Medicare OP Drug reimbursement methodology for certain hospitals […]
Compliance is often a misunderstood word that most healthcare professionals associate with spending more time and money. Typically, compliance is defined as a certification or confirmation that the doer of an action or manufacturer of a product meets the requirements of accepted practices, legislation, prescribed regulations, specified standard or terms of a contract. 340B Program […]
CMS continues to refine the uncompensated care calculation. Three factors are utilized to calculate uncompensated care reimbursement for IPPS hospitals. Factor 3 is developed by compiling the cost of uncompensated care that is reported on the Medicare cost report Worksheet S-10. Effective with federal fiscal year 2020, worksheet S-10 will fully utilize uncompensated care data […]